Miconazole is a broad-spectrum antifungal agent belonging to the imidazole class, widely indicated for the treatment of dermatological and vaginal fungal infections, including candidiasis and ringworm,… Read more





Miconazole is a broad-spectrum antifungal agent belonging to the imidazole class, widely indicated for the treatment of dermatological and vaginal fungal infections, including candidiasis and ringworm, by inhibiting the synthesis of ergosterol in fungal cell membranes. To support rigorous quality control and regulatory compliance, pharmaceutical laboratories utilize comprehensive reference standards for this compound. The provided collection includes the active pharmaceutical ingredient (API), as well as a range of pharmacopeial and non-pharmacopeial impurities, comprising synthetic intermediates, process-related compounds, and degradation products. These materials are essential for accurate impurity profiling, method validation, and stability studies. Additionally, the availability of stable isotope labelled compounds supports advanced analytical testing and quantification, ensuring that high-precision methods remain robust and reliable throughout the drug development and manufacturing lifecycle.